News

You can now access the 2024 Annual Report of IR Sant Pau

The Sant Pau Research Institute has published its 2024 Annual Report, a yearly overview of a full year of research, collective effort, and meaningful results. The document outlines ...

IR Sant Pau Leads New Clinical Trial to Optimize Antibiotic Treatment for Complicated Pediatric Appendicitis

The Sant Pau Research Institute (IR Sant Pau) is leading the new multicenter clinical trial FTAA (Fast Track in Acute Appendicitis), aimed at improving the postoperative management of complicated appe...

The Combination of Simvastatin and Rifaximin Offers No Clinical Benefits for Patients With Decompensated Cirrhosis

The CIBEREHD group from the Digestive Diseases Department at Hospital de Sant Pau has participated in an international clinical trial recently published in JAMA (Journal of the American Medical Associ...

Sant Pau Receives Best Oral Presentation Award at SENEC 2025 for Pioneering Study on Neuromodulation in Parkinson’s Disease

The Neuromodulation in Movement Disorders Group at Hospital de Sant Pau has received the Best Oral Presentation Award at the 2025 Congress of the Spanish Society of Neurosurgery (SENEC), recently held...

A New Blood Biomarker Predicts the Progression of Alzheimer’s Disease Even in Its Earliest Stages

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression o...